Literature DB >> 2692430

Stable recombinant avirulent Salmonella vaccine strains.

R Curtiss1, S M Kelly, P A Gulig, K Nakayama.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2692430     DOI: 10.1007/978-1-4757-2046-4_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  6 in total

Review 1.  New technologies in developing recombinant attenuated Salmonella vaccine vectors.

Authors:  Shifeng Wang; Qingke Kong; Roy Curtiss
Journal:  Microb Pathog       Date:  2012-11-08       Impact factor: 3.738

Review 2.  New technologies in using recombinant attenuated Salmonella vaccine vectors.

Authors:  Roy Curtiss; Wei Xin; Yuhua Li; Wei Kong; Soo-Young Wanda; Bronwyn Gunn; Shifeng Wang
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

3.  Site-specific integration of mycobacteriophage L5: integration-proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Guérin.

Authors:  M H Lee; L Pascopella; W R Jacobs; G F Hatfull
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

4.  Molecular imaging of biological gene delivery vehicles for targeted cancer therapy: beyond viral vectors.

Authors:  Jung-Joon Min; Vu H Nguyen; Sanjiv S Gambhir
Journal:  Nucl Med Mol Imaging       Date:  2010-02-26

5.  The Asd(+)-DadB(+) dual-plasmid system offers a novel means to deliver multiple protective antigens by a recombinant attenuated Salmonella vaccine.

Authors:  Wei Xin; Soo-Young Wanda; Xiangmin Zhang; Javier Santander; Giorgio Scarpellini; Karen Ellis; Praveen Alamuri; Roy Curtiss
Journal:  Infect Immun       Date:  2012-08-06       Impact factor: 3.441

6.  PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae.

Authors:  Wei Xin; Yuhua Li; Hua Mo; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2009-08-17       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.